Drug Chatter -- Tracking biopharma stock chatter

Profile for Akebia Therapeutics, Inc. (AKBA)

« Back to company index

AKBA Chatter Timeline

Stock Ticker for AKBA

Most Active Tweeters for AKBA

UserTweets
@ConsumerFeed 8
@stocknewstimes 6
@SleekMoneycom 5
@dispatchtribune 5
@portefeuillefun 5

Recent Tweets for AKBA

ConsumerFeed @ConsumerFeed
Akebia Therapeutics, Inc. $AKBA Receives Buy Rating from HC Wainwright https://t.co/Vi9SF3lzey
November 16th 2017, 9:11pm
dakotafinancial @dakotafinancial
Akebia Therapeutics, Inc. $AKBA Receives Buy Rating from HC Wainwright https://t.co/pRPRDSAwG2
November 16th 2017, 9:11pm
ZolmaxNews @ZolmaxNews
361 Capital LLC Takes $2.74 Million Position in Akebia Therapeutics, Inc. $AKBA https://t.co/n8AM9SnSlP
November 16th 2017, 2:11pm
JohnAGarabo @JohnAGarabo
RT @akebiatx: NEWS: Akebia Therapeutics to Participate in Upcoming Investor Conferences https://t.co/pHHRfvbtoQ $AKBA
November 16th 2017, 8:11am
akebiatx @akebiatx
NEWS: Akebia Therapeutics to Participate in Upcoming Investor Conferences https://t.co/pHHRfvbtoQ $AKBA
November 16th 2017, 8:11am
stockboardinc @stockboardinc
$AKBA Akebia Therapeutics to Participate in Upcoming Investor Conferences... - https://t.co/TyOAvxszUq
November 16th 2017, 8:11am
ProTradersNews @ProTradersNews
$AKBA: Akebia Therapeutics to Participate in Upcoming Investor Conferences: https://t.co/xpodARwWv1
November 16th 2017, 8:11am
TranscriptDaily @TranscriptDaily
Akebia Therapeutics, Inc. $AKBA Upgraded at Zacks Investment Research https://t.co/GAopZ7q80p
November 16th 2017, 5:11am
storminvestor @storminvestor
Analysts Set Akebia Therapeutics, Inc. $AKBA Price Target at $20.67 https://t.co/b5yLRroZfd
November 15th 2017, 8:11pm
RoccoLefkowitz @RoccoLefkowitz
Bought back 2000 $AKBA at 14.38 for total 5000 shares cost basis 11.82. I should have taken off another 1000 shares… https://t.co/0Zp454ehF4
November 15th 2017, 11:11am
dispatchtribune @dispatchtribune
Zacks Investment Research Upgrades Akebia Therapeutics, Inc. $AKBA to Buy https://t.co/vwJDQm3cI6
November 15th 2017, 10:11am
stocknewsdotcom @stocknewsdotcom
$AKBA H.C. Wainwright & Co. reiterates Buy rating, $24 PT https://t.co/IUgd9Q9e5l
November 15th 2017, 9:11am
WatchlistN @WatchlistN
HC Wainwright Reaffirms “Buy” Rating for Akebia Therapeutics, Inc. $AKBA https://t.co/Bdk6JNnLNU
November 15th 2017, 7:11am
efinancialpub @efinancialpub
RT @RatingsNetwork: Akebia Therapeutics's buy rating reiterated at HC Wainwright. $24.00 PT. https://t.co/d1pwluEYnL $AKBA #AKBA
November 15th 2017, 7:11am
skaushi @skaushi
RT @odibro: $AKBA reiterated with a buy at HCW with $24 PT
November 15th 2017, 7:11am
efinancialpub @efinancialpub
RT @AmericanBanking: Akebia Therapeutics's buy rating reiterated at HC Wainwright. $24.00 PT. https://t.co/Z0O4Sp9SC8 $AKBA #AKBA
November 15th 2017, 7:11am
AmericanBanking @AmericanBanking
Akebia Therapeutics's buy rating reiterated at HC Wainwright. $24.00 PT. https://t.co/Z0O4Sp9SC8 $AKBA #AKBA
November 15th 2017, 7:11am
RatingsNetwork @RatingsNetwork
Akebia Therapeutics's buy rating reiterated at HC Wainwright. $24.00 PT. https://t.co/d1pwluEYnL $AKBA #AKBA
November 15th 2017, 7:11am
odibro @odibro
$AKBA reiterated with a buy at HCW with $24 PT
November 15th 2017, 7:11am
ARatings @ARatings
H.C. Wainwright Issues a Buy Rating on Akebia Therapeutics $AKBA https://t.co/S7QsCbqk3J
November 15th 2017, 7:11am
IRAMarketReport @IRAMarketReport
Northern Trust Corp Grows Position in Akebia Therapeutics, Inc. $AKBA https://t.co/29JOCffgIQ
November 15th 2017, 6:11am
chaffeybreeze @chaffeybreeze
Northern Trust Corp Grows Position in Akebia Therapeutics, Inc. $AKBA https://t.co/ESm4m5PXVP
November 15th 2017, 5:11am
WeekHerald @WeekHerald
Akebia Therapeutics $AKBA Receives Daily Media Impact Rating of 0.04 https://t.co/uQbZpOnebp
November 15th 2017, 2:11am
dispatchtribune @dispatchtribune
Akebia Therapeutics’ $AKBA Hold Rating Reiterated at Royal Bank Of Canada https://t.co/wzzGMZe0N8
November 15th 2017, 12:11am
SleekMoneycom @SleekMoneycom
Akebia Therapeutics, Inc. $AKBA Upgraded to “Buy” at Zacks Investment Research https://t.co/tUnYPHC74A
November 14th 2017, 6:11pm
stocknewstimes @stocknewstimes
Akebia Therapeutics, Inc. $AKBA Upgraded to “Buy” at Zacks Investment Research https://t.co/MndFBIq1MF
November 14th 2017, 6:11pm
ZolmaxNews @ZolmaxNews
Akebia Therapeutics, Inc. $AKBA Upgraded to “Buy” at Zacks Investment Research https://t.co/3RBHETfoDc
November 14th 2017, 5:11pm
stocknewstimes @stocknewstimes
Akebia Therapeutics $AKBA Earns Media Sentiment Rating of 0.02 https://t.co/PTFSSN0UXo
November 14th 2017, 2:11pm
SleekMoneycom @SleekMoneycom
Akebia Therapeutics $AKBA Earns Media Sentiment Rating of 0.02 https://t.co/e9dnzFjgrX
November 14th 2017, 1:11pm
portefeuillefun @portefeuillefun
RT @Biotech_DD: $AKBA RBC notes from Fresenius MedCare Roadshow https://t.co/iTncfkTpP4
November 14th 2017, 1:11pm
Biotech_DD @Biotech_DD
$AKBA RBC notes from Fresenius MedCare Roadshow https://t.co/iTncfkTpP4
November 14th 2017, 1:11pm
intercooleronli @intercooleronli
Akebia Therapeutics, Inc. $AKBA Lifted to Buy at Zacks Investment Research https://t.co/xmhdU76Cw3
November 13th 2017, 8:11pm
ConsumerFeed @ConsumerFeed
Akebia Therapeutics, Inc. $AKBA Lifted to Buy at Zacks Investment Research https://t.co/dXaH2V7i6r #acn
November 13th 2017, 8:11pm
ConsumerFeed @ConsumerFeed
Akebia Therapeutics upgraded by Zacks Investment Research to buy. $17.00 PT. https://t.co/E2aLqTA29G $AKBA #AKBA
November 13th 2017, 8:11pm
CFinancialNews @CFinancialNews
Akebia Therapeutics, Inc. $AKBA Lifted to Buy at Zacks Investment Research https://t.co/i8WqjhN3Yv
November 13th 2017, 8:11pm
RatingsNetwork @RatingsNetwork
Akebia Therapeutics upgraded by Zacks Investment Research to buy. $17.00 PT. https://t.co/u0ZiWUsVMe $AKBA #AKBA
November 13th 2017, 8:11pm
ledgerzette @ledgerzette
Fmr LLC Acquires 105,100 Shares of Akebia Therapeutics, Inc. $AKBA https://t.co/Z17o201FIK
November 12th 2017, 8:11pm
TranscriptDaily @TranscriptDaily
Akebia Therapeutics, Inc. $AKBA Earns Buy Rating from Mizuho https://t.co/LlCYpyGVDA
November 12th 2017, 4:11pm
CFinancialNews @CFinancialNews
Akebia Therapeutics, Inc. $AKBA Given Average Recommendation of “Buy” by Brokerages https://t.co/1BTItr4wMm
November 12th 2017, 10:11am
intercooleronli @intercooleronli
Akebia Therapeutics, Inc. $AKBA Given Average Recommendation of “Buy” by Brokerages https://t.co/pghxPjhZsh
November 12th 2017, 10:11am
ConsumerFeed @ConsumerFeed
Akebia Therapeutics, Inc. $AKBA Given Average Recommendation of “Buy” by Brokerages https://t.co/8JI3hwtSzB #acn
November 12th 2017, 10:11am
AmericanBanking @AmericanBanking
Akebia Therapeutics, Inc. $AKBA Given Average Recommendation of “Buy” by Brokerages https://t.co/ojig0XoTNJ
November 12th 2017, 10:11am
storminvestor @storminvestor
Somewhat Positive Press Coverage Somewhat Unlikely to Impact Akebia Therapeutics $AKBA Stock Price https://t.co/DgCHxdX63A
November 11th 2017, 7:11pm
WeekHerald @WeekHerald
Akebia Therapeutics, Inc. $AKBA Earns Hold Rating from Royal Bank of Canada https://t.co/qIr7wg0H48
November 11th 2017, 3:11pm
IRAMarketReport @IRAMarketReport
Akebia Therapeutics, Inc. $AKBA Holdings Increased by Nationwide Fund Advisors https://t.co/Wzj3DJLmZb
November 11th 2017, 5:11am
chaffeybreeze @chaffeybreeze
Akebia Therapeutics, Inc. $AKBA Holdings Increased by Nationwide Fund Advisors https://t.co/jhoejrIUqI
November 11th 2017, 5:11am
SMA_alpha @SMA_alpha
$AKBA High Positive investor sentiment Nov 10, 2:19 PM ET, see chart at https://t.co/u2qO9jJYex #sentiment #trading #stocks
November 10th 2017, 2:11pm
ProTradersNews @ProTradersNews
$AKBA: Akebia Therapeutics Is A Buy With The Recent Stock Price Pullback: https://t.co/YX9TYgtDcn
November 10th 2017, 12:11pm
stocknewstimes @stocknewstimes
First Manhattan Co. Reduces Position in Akebia Therapeutics, Inc. $AKBA https://t.co/n7ZLXBuskU
November 10th 2017, 12:11pm
TickerReport @TickerReport
Akebia Therapeutics, Inc. $AKBA Announces Earnings Results https://t.co/z8rCK5Jleo
November 10th 2017, 11:11am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.